RT @ericdeinmd: #ACR21 L21. REOVAS: RTX for EGPA âï¸CYC traditionally preferred for 5-factor score>0 â¶ï¸Remissi
Tweet Content
#ACR21 L21. REOVAS: RTX for EGPA
⭐️CYC traditionally preferred for 5-factor score>0
▶️Remission rates and relapse-free survival comparable bw RTX and conventional. RTX not superior for induction
▶️No diff in ANCA+/-, naive v relapse, FFS
https://t.co/cuM9LcEr4u @Rheumnow
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off